CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Endo Pharmaceuticals Inc. v. Impax Laboratories Inc.

1:14-cv-01383

Overview

Case Number 1:14-cv-01383
Filing Date 2014-11-07
Status Terminated
Termination Date 2018-02-27
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Impax Laboratories Inc. Operating Company

Represented By

6 Attorneys Listed

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

Maureen L. Rurka

Email: MRurka@winston.com

Lesley M. Hamming

Email: lesley.hamming@lw.com

Kevin E. Warner

Email: kwarner@winston.com

David A. Bilson

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200
Fax: +1 (302) 655-4210

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Plaintiff

Mallinckrodt LLC Operating Company

Represented By

3 Attorneys Listed

Stephen J. Kraftschik

Polsinelli PC

Tel: +1 (302) 252-0926
Fax: +1 (302) 252-0921

222 Delaware Avenue, Suite 1101, Wilmington, DE 19801

Julia Heaney

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Endo Pharmaceuticals Inc. Operating Company

Represented By

7 Attorneys Listed

Stephen J. Kraftschik

Polsinelli PC

Tel: +1 (302) 252-0926
Fax: +1 (302) 252-0921

222 Delaware Avenue, Suite 1101, Wilmington, DE 19801

Sharon K. Gagliardi

Email: sharon.gagliardi@dechert.com

Julie Latsko

UNDELIVERABLE EMAIL 4/13/2017

Julia Heaney

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Joseph J. Gribbin

Email: joseph.gribbin@dechert.com

Blake B. Greene

Email: blake.greene@dechert.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 7 proceedings
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (7 found):
U.S. Courts: 7
U.S. District Court 2014-11-07
1:14-cv-01382

Endo Pharmaceuticals Inc. v. Amneal Pharmaceuticals LLC

Asserted Patent
Status: DED
U.S. District Court 2014-11-07
1:14-cv-01385

Endo Pharmaceuticals Inc. v. Par Pharmaceutical Companies Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-11-07
1:14-cv-01389

Endo Pharmaceuticals Inc. v. Teva Pharmaceuticals USA Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-11-07
1:14-cv-01384

Endo Pharmaceuticals Inc. v. Impax Laboratories Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-11-07
1:14-cv-01388

Endo Pharmaceuticals Inc. v. Sandoz Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-11-07
1:14-cv-01381

Endo Pharmaceuticals Inc. v. Actavis LLC

Asserted Patent
Status: DED
U.S. District Court 2014-11-07
1:14-cv-01387

Endo Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Limited

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8808737
Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment
Filed: 2010-03-03
Issued: 2014-08-19
Active (3.3 yrs remaining)
Expires: 2030-03-03
US8871779
Process for preparing morphinan-6-one products with low levels of α,β-unsaturated ketone compounds
Filed: 2007-03-02
Issued: 2014-10-28
Active (3.0 yrs remaining) +996d PTA
Expires: 2029-11-22

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

31

Dispositive

9

Granted

0

Denied

1

Pending / Review

25

Motions by Category

Procedural / Extension Motion 11 Motion to Transfer Venue (28 U.S.C. § 1404) 9 Claim Construction / Markman Filing 3 Motion to Stay 8

Key Dispositive Motions & Rulings

Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
NOTICE of Withdrawal of Defendants' Motion to Transfer Action to Southern District of New York (D.I. 13 ), by Impax Laboratories Inc., ThoRx Laboratories Inc., ...
Entry #34 • 2015-04-28 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
ORAL ORDER: The oral argument scheduled for 5/11/2015, is CANCELED per the Notice of Withdrawal of Defendants' Motion to Transfer Action to Southern District of...
Entry #35 • 2015-04-28 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
ANSWERING BRIEF in Opposition re 13 MOTION to Transfer Case to Southern District of New York filed by Endo Pharmaceuticals Inc., Mallinckrodt LLC.Reply Brief du...
Entry #25 • 2015-03-10 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
STIPULATION TO EXTEND TIME for Plaintiffs to Respond to Motion to Transfer and Defendant to File Reply Brief to March 10, 2015 and April 28, 2015, respectively ...
Entry #22 • 2015-03-02 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Pending
SO ORDERED, re 22 STIPULATION TO EXTEND TIME to Respond to Motion to Transfer and to File Reply Brief to March 10, 2015, and April 28, 2015, filed by Mallinckro...
Entry #— • 2015-03-02
Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
SO ORDERED, re 18 STIPULATION TO EXTEND TIME to answer counterclaims, and submit briefing, filed by Mallinckrodt LLC, Endo Pharmaceuticals Inc. (Reset Answer De...
Entry #19 • 2015-02-05 Document →

Docket Entries

(171 total)
Pleading / Complaint

COMPLAINT filed against Impax Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1622581.) - filed by Mallinckrodt LLC, Endo Phamaceuticals Inc.. (Attachments: # 1 Exhibit A&B, # 2 Civil Cover Sheet)(mas) (Entered: 11/10/2014)

Entry #1 • 2014-11-07
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mas) (Entered: 11/10/2014)

Entry #2 • 2014-11-07
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,808,737 B2; 8,871,779 B2;. (mas) (Entered: 11/10/2014)

Entry #3 • 2014-11-07
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Endo International PLC for Endo Phamaceuticals Inc. filed by Endo Phamaceuticals Inc.. (mas) (Entered: 11/10/2014)

Entry #4 • 2014-11-07
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mallinckrodt plc, Other Affiliate Mallinckrodt Inc. for Mallinckrodt LLC filed by Mallinckrodt LLC. (mas) (Entered: 11/10/2014)

Entry #5 • 2014-11-07
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc